SETH SANDESH

CIK 00015661752 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001566175

Recent Transactions

50 trades

Tax Payment
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2025-08-18$1.71/sh−120,900→ 184,481 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−33,333→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−25,000→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−310,182→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−984,367→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−827,366→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−139,062→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−16,666→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−50,000→ 0 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2023-12-28+984,367→ 984,367 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2022-08-17+300,000→ 305,381 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2022-07-01+827,366→ 827,366 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2021-09-01+310,182→ 310,182 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2020-08-12+139,062→ 139,062 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Options to purchase common stock
2019-07-12$0.23/sh+1,500,000→ 1,500,000 total
Exercise of In-Money
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2019-02-21$0.60/sh+8,125→ 161,458 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2018-12-10$0.44/sh+10,000→ 153,333 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common stock
2018-07-17$0.79/sh+10,000→ 143,333 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Options to purchase common stock
2018-07-13$0.78/sh+1,000,000→ 1,000,000 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2018-04-19$0.38/sh+5,000→ 133,333 total
Other
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2018-03-06$0.50/sh+52,500→ 128,333 total
Other
Actinium Pharmaceuticals, Inc.$ATNM
Series A Warrants
2018-03-06$0.50/sh+13,125→ 13,125 total
Other
Actinium Pharmaceuticals, Inc.$ATNM
Series B Warrants
2018-03-06$0.50/sh+39,375→ 39,375 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2017-08-02$0.75/sh+33,333→ 75,833 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2017-06-15$1.16/sh+5,000→ 42,500 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common stock
2017-06-15$1.17/sh+2,500→ 37,500 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Options to purchase common stock
2017-03-14$1.39/sh+750,000→ 750,000 total
Other
Actinium Pharmaceuticals, Inc.$ATNM
Warrant to purchase common stock
2017-03-14$0.78/sh+64,746→ 64,746 total
Other
Actinium Pharmaceuticals, Inc.$ATNM
Warrant to purchase common stock
2017-03-14$2.34/sh−57,212→ 0 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Warrant to purchase common stock
2017-03-14$2.34/sh+57,212→ 57,212 total
Other
Actinium Pharmaceuticals, Inc.$ATNM
Warrant to purchase common stock
2017-03-14$0.78/sh+99,619→ 99.619 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common stock
2016-12-30$0.88/sh+5,000→ 35,000 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common stock
2016-12-12$0.98/sh+5,000→ 30,000 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2016-04-18$1.98/sh+5,000→ 23,500 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2016-04-18$1.99/sh+1,500→ 25,000 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Options to purchase common stock
2016-04-15$1.99/sh+500,000→ 500,000 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2016-04-15$2.00/sh+2,000→ 17,000 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2016-04-15$2.01/sh+1,500→ 18,500 total
Purchase
Actinium Pharmaceuticals, Inc.$ATNM
Common Stock
2016-04-14$2.00/sh+5,000→ 15,000 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-15$3.43/sh+100→ 120,858 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-15$2.91/sh+2,000→ 118,258 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-15$3.30/sh+2,500→ 120,758 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-15$3.50/sh+2,400→ 123,258 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-15$3.00/sh+2,500→ 116,258 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-14$2.50/sh+140→ 104,198 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-14$2.90/sh+500→ 106,258 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-14$2.97/sh+1,000→ 107,258 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-14$3.00/sh+1,500→ 113,758 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-14$2.50/sh+800→ 104,058 total
Purchase
RELMADA THERAPEUTICS, INC.$RLMD
Common stock
2015-12-14$2.99/sh+5,000→ 112,258 total

Companies

Recent Filings

Address

300 E 93RD STREET, #20-B

NEW YORK, NY, 10128

View on SEC.gov